Glucagon phosphorylates serine 552 of β-catenin leading to increased expression of cyclin D1 and c-Myc in the isolated rat liver

被引：13

作者：

Chowdhury, Md. Kamrul H. ^{[1
]}

Montgomery, Magda K. ^{[1
]}

Morris, Margaret J. ^{[1
]}

Cognard, Emmanuelle ^{[2
]}

Shepherd, Peter R. ^{[2
]}

Smith, Greg C. ^{[1
]}

机构：

[1] UNSW Australia, Dept Pharmacol, Sydney, NSW, Australia

[2] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand

来源：

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY | 2015年 / 121卷 / 03期

关键词：

beta-Catenin; cancer; glucagon; T2D; PREEXISTING DIABETES-MELLITUS; CANCER-RISK; COLORECTAL-CANCER; HEPATOCELLULAR CARCINOMAS; INSULIN-RESISTANCE; MOLECULAR LINKS; PROSTATE-CANCER; KIDNEY CANCER; GLUCOSE; METAANALYSIS;

D O I：

10.3109/13813455.2015.1048693

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In the last 20 years the prevalence of metabolic disorders, in particular type 2 diabetes (T2D), has more than doubled. Recently, a strong link between T2D and cancer, in particularly liver cancer has been reported. However, the mechanism connecting the development of type 2 diabetes and cancer remains unknown. One of the biggest drivers of liver cancer is alterations in the Wnt/beta-catenin pathway. In this study, we aimed to identify the effect of glucagon on beta-catenin in the isolated rat liver. We found glucagon, which is substantially raised in patients with T2D, rapidly phosphorylates beta-catenin on serine 552 that is associated with increased expression of genes cyclin D1 (CCND1) and c-Myc (MYC), which are known to be involved in liver cancer. This finding may explain the increased risk of liver cancer in people with T2D.

引用

页码：88 / 96

页数：9

共 72 条

[1] beta-catenin is a target for the ubiquitin-proteasome pathway [J].

Aberle, H ;

Bauer, A ;

Stappert, J ;

Kispert, A ;

Kemler, R .

EMBO JOURNAL, 1997, 16 (13) :3797-3804

[2] The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention [J].

Alao, John P. .

MOLECULAR CANCER, 2007, 6 (1)

[3] Glucose induces an autocrine activation of the Wnt/β-catenin pathway in macrophage cell lines [J].

Anagnostou, Sasha H. ;

Shepherd, Peter R. .

BIOCHEMICAL JOURNAL, 2008, 416 :211-218

[4] Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms [J].

Arcidiacono, Biagio ;

Iiritano, Stefania ;

Nocera, Aurora ;

Possidente, Katiuscia ;

Nevolo, Maria T. ;

Ventura, Valeria ;

Foti, Daniela ;

Chiefari, Eusebio ;

Brunetti, Antonio .

EXPERIMENTAL DIABETES RESEARCH, 2012,

[5] Hyperinsulinemia predicts fetal liver cancer but is inversely associated with fatal cancer at some other sites -: The Paris Prospective Study [J].

Balkau, B ;

Kahn, HS ;

Courbon, D ;

Eschwège, E ;

Ducimetrière, P .

DIABETES CARE, 2001, 24 (05) :843-849

[6] Diabetes mellitus and incidence and mortality of kidney cancer: A meta-analysis [J].

Bao, Cuiping ;

Yang, Xilin ;

Xu, Weili ;

Luo, Hongbin ;

Xu, Zhongliang ;

Su, Cheng ;

Qi, Xiuying .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (04) :357-364

[7] A new view of diabetic retinopathy: a neurodegenerative disease of the eye [J].

Barber, AJ .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (02) :283-290

[8] Effects of type 2 diabetes on the regulation of hepatic glucose metabolism [J].

Basu, A ;

Shah, P ;

Nielsen, M ;

Basu, R ;

Rizza, RA .

JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (06) :366-374

[9] Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies [J].

Ben, Qiwen ;

Xu, Maojin ;

Ning, Xiaoyan ;

Liu, Jun ;

Hong, Shangyou ;

Huang, Wen ;

Zhang, Huagao ;

Li, Zhaoshen .

EUROPEAN JOURNAL OF CANCER, 2011, 47 (13) :1928-1937

[10] Inflammation and Liver Cancer New Molecular Links [J].

Berasain, C. ;

Castillo, J. ;

Perugorria, M. J. ;

Latasa, M. U. ;

Prieto, J. ;

Avila, M. A. .

STEROID ENZYMES AND CANCER, 2009, 1155 :206-221

← 1 2 3 4 5 6 7 8 →